Time to get rid of the Investigator's Global Assessment as the primary outcome for clinical trials in atopic dermatitis?
DSpace/Manakin Repository
Time to get rid of the Investigator's Global Assessment as the primary outcome for clinical trials in atopic dermatitis?
de Bruin-Weller, M
(2019) British Journal of Dermatology, volume 181, issue 1, pp. 12 - 13
(Comment)
Download/Full Text
The full text of this publication is not available.
Version on publisher website for UU-students and staff
Version on publisher website
Keywords: Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Dermatitis, Atopic, Eczema, Humans, Skin, Journal Article, Comment
DOI:
https://doi.org/10.1111/bjd.18037
ISSN: 0007-0963
Publisher: Wiley-Blackwell
Note: Copyright: Copyright 2019 Elsevier B.V., All rights reserved.
(Peer reviewed)